Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | SRC | P12931 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | ANPEP | P15144 | 2/20 | 0.42 |
| ▸ | LAP3 | P28838 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16136684 | 0.91 | L3MBTL1 (0.46) | L3MBTL1SRCNPSR1MEN1KMT2A | |
| SCHEMBL5528971 | 0.91 | L3MBTL1 (0.46) | L3MBTL1SRCNPSR1MEN1KMT2A | |
| SCHEMBL29267266 | 0.86 | L3MBTL1 (0.49) | L3MBTL1SRCNPSR1MEN1KMT2A | |
| SCHEMBL16695020 | 0.84 | L3MBTL1 (0.41) | L3MBTL1SRCNPSR1MEN1KMT2A | |
| SCHEMBL10780226 | 0.82 | L3MBTL1 (0.52) | L3MBTL1SRCNPSR1MEN1KMT2A | |
| SCHEMBL19072606 | 0.81 | L3MBTL1 (0.50) | L3MBTL1SRCNPSR1MEN1KMT2A | |
| SCHEMBL28659355 | 0.79 | ANPEP (0.53) | L3MBTL1SRCNPSR1MEN1KMT2A | |
| SCHEMBL14305183 | 0.78 | L3MBTL1 (0.47) | L3MBTL1SRCNPSR1MEN1KMT2A | |
| SCHEMBL14306727 | 0.78 | L3MBTL1 (0.47) | L3MBTL1SRCNPSR1MEN1KMT2A | |
| SCHEMBL5958828 | 0.78 | SRC (0.50) | L3MBTL1SRCNPSR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2910619-A1 | LIGHT-EMITTING MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENT DEVICE USING SAME, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE | Idemitsu Kosan Co., Ltd (JP) | 2015-08-26 | — | — | EP | disclosed |
| US-20070152565-A1 | Light-emitting material for organic electroluminescent device, organic electroluminescent device using same, and material for organic electroluminescent device | IDEMITSU KOSAN CO., LTD. (JP) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070152565-A1 | Light-emitting material for organic electroluminescent device, organic electroluminescent device using same, and material for organic electroluminescent device | L1CAM, EBPL, APOL1 | L3MBTL1 430/4885SRC 3261/4885NPSR1 4879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.